Cargando…
A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy
Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by pathogenic variants in the DYSF gene. While several animal models of dysferlinopathy have been developed, most of them involve major disruptions of the Dysf gene locus that are not optimal for studying human dysferli...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216094/ https://www.ncbi.nlm.nih.gov/pubmed/37239109 http://dx.doi.org/10.3390/biomedicines11051438 |
_version_ | 1785048216381685760 |
---|---|
author | Ballouhey, Océane Chapoton, Marie Alary, Benedicte Courrier, Sébastien Da Silva, Nathalie Krahn, Martin Lévy, Nicolas Weisleder, Noah Bartoli, Marc |
author_facet | Ballouhey, Océane Chapoton, Marie Alary, Benedicte Courrier, Sébastien Da Silva, Nathalie Krahn, Martin Lévy, Nicolas Weisleder, Noah Bartoli, Marc |
author_sort | Ballouhey, Océane |
collection | PubMed |
description | Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by pathogenic variants in the DYSF gene. While several animal models of dysferlinopathy have been developed, most of them involve major disruptions of the Dysf gene locus that are not optimal for studying human dysferlinopathy, which is often caused by single nucleotide substitutions. In this study, the authors describe a new murine model of dysferlinopathy that carries a nonsense mutation in Dysf exon 32, which has been identified in several patients with dysferlinopathy. This mouse model, called Dysf (p.Y1159X/p.Y1159X), displays several molecular, histological, and functional defects observed in dysferlinopathy patients and other published mouse models. This mutant mouse model is expected to be useful for testing various therapeutic approaches such as termination codon readthrough, pharmacological approaches, and exon skipping. Therefore, the data presented in this study strongly support the use of this animal model for the development of preclinical strategies for the treatment of dysferlinopathies. |
format | Online Article Text |
id | pubmed-10216094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102160942023-05-27 A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy Ballouhey, Océane Chapoton, Marie Alary, Benedicte Courrier, Sébastien Da Silva, Nathalie Krahn, Martin Lévy, Nicolas Weisleder, Noah Bartoli, Marc Biomedicines Article Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by pathogenic variants in the DYSF gene. While several animal models of dysferlinopathy have been developed, most of them involve major disruptions of the Dysf gene locus that are not optimal for studying human dysferlinopathy, which is often caused by single nucleotide substitutions. In this study, the authors describe a new murine model of dysferlinopathy that carries a nonsense mutation in Dysf exon 32, which has been identified in several patients with dysferlinopathy. This mouse model, called Dysf (p.Y1159X/p.Y1159X), displays several molecular, histological, and functional defects observed in dysferlinopathy patients and other published mouse models. This mutant mouse model is expected to be useful for testing various therapeutic approaches such as termination codon readthrough, pharmacological approaches, and exon skipping. Therefore, the data presented in this study strongly support the use of this animal model for the development of preclinical strategies for the treatment of dysferlinopathies. MDPI 2023-05-13 /pmc/articles/PMC10216094/ /pubmed/37239109 http://dx.doi.org/10.3390/biomedicines11051438 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ballouhey, Océane Chapoton, Marie Alary, Benedicte Courrier, Sébastien Da Silva, Nathalie Krahn, Martin Lévy, Nicolas Weisleder, Noah Bartoli, Marc A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title | A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title_full | A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title_fullStr | A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title_full_unstemmed | A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title_short | A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy |
title_sort | dysferlin exon 32 nonsense mutant mouse model shows pathological signs of dysferlinopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216094/ https://www.ncbi.nlm.nih.gov/pubmed/37239109 http://dx.doi.org/10.3390/biomedicines11051438 |
work_keys_str_mv | AT ballouheyoceane adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT chapotonmarie adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT alarybenedicte adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT courriersebastien adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT dasilvanathalie adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT krahnmartin adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT levynicolas adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT weisledernoah adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT bartolimarc adysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT ballouheyoceane dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT chapotonmarie dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT alarybenedicte dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT courriersebastien dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT dasilvanathalie dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT krahnmartin dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT levynicolas dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT weisledernoah dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy AT bartolimarc dysferlinexon32nonsensemutantmousemodelshowspathologicalsignsofdysferlinopathy |